Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi-center US-based longitudinal registry
Document Type
Journal Article
Publication Date
2-1-2022
Journal
International journal of rheumatic diseases
Volume
25
Issue
2
DOI
10.1111/1756-185X.14253
Keywords
interstitial lung disease; registry; restrictive lung disease; scleroderma; systemic sclerosis
Abstract
AIM: Interstitial lung disease (ILD) is the leading cause of disease-related death in systemic sclerosis (SSc). Here, we assess baseline characteristics of SSc subjects with and without restrictive lung disease (RLD) in a multi-center, US-based registry. METHODS: SSc patients within 5 years of disease onset were enrolled in the Collaborative National Quality and Efficacy Registry (CONQUER), a multi-center US-based registry of SSc study participants (age ≥ 18 years) enrolled at 13 expert centers. All subjects met 2013 American College of Rheumatology / European League Against Rheumatism criteria. Subjects with a pulmonary function test (PFT) at baseline before April 1, 2020 were included. High-resolution computed tomography scan of the chest was not available to characterize ILD for all subjects. RLD was defined as forced vital capacity (FVC) <80% or total lung capacity (TLC) <80% predicted. RESULTS: There were 160 (45%) SSc subjects characterized as having RLD. There was no significant difference in age, gender or disease duration. RLD subjects had a mean disease duration from date of first non-Raynaud's symptom of 2.6 years and a mean FVC% predicted of 67% at baseline. In multivariable analysis, non-White race, higher physician global health assessment and modified Medical Research Council (mMRC) dyspnea scores, were independently associated with RLD. In the subgroup of RLD subjects with ILD, ILD had a negative correlation with RNA polymerase III antibody. CONCLUSION: CONQUER is the largest, multi-center, prospective cohort of early SSc patients in the US. Non-White race was independently associated with RLD. In addition, 45% of CONQUER subjects already had RLD, highlighting the importance of screening for SSc-ILD at initial diagnosis.
APA Citation
Castelino, Flavia V.; VanBuren, John M.; Startup, Emily; Assassi, Shervin; Bernstein, Elana J.; Chung, Lorinda; Correia, Chase; Evnin, Luke B.; Frech, Tracy M.; Gordon, Jessica K.; Hant, Faye N.; Hummers, Laura K.; Khanna, Dinesh; Sandorfi, Nora; Shah, Ami A.; Shanmugam, Victoria K.; and Steen, Virginia, "Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi-center US-based longitudinal registry" (2022). GW Authored Works. Paper 362.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/362
Department
Anatomy and Regenerative Biology